search
Back to results

Feasibility of a Home Exercise Program to Manage Post-transplant Metabolic Syndrome

Primary Purpose

Metabolic Syndrome

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Exercise Training
Sponsored by
University Health Network, Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Metabolic Syndrome focused on measuring Lung Transplant Recipients, Liver Transplant Recipients, Exercise Training

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult lung and liver transplant recipients 12 to 18 months post-transplant
  • Presence of 2 or more metabolic risk factors (hypertension, hyperlipidemia, diabetes, obesity)

Exclusion Criteria:

  • Active cardiovascular disease (recent heart attack, significant coronary artery disease on cardiac catheterization, heart failure, uncontrolled arrhythmias, chest pain, dizziness, or fainting in the last 3 months)
  • Neuro-muscular disease or orthopedic limitations
  • Physically active with ≥ 150 minutes/week of moderate-intensity aerobic physical activity

Sites / Locations

  • University Health Network - Toronto General HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Home Exercise Group

Control Group

Arm Description

The home-based exercise group will be asked to exercise 3 to 5 times per week (≥ 150 minutes of aerobic exercises (i.e. walking, cycling, or treadmill) of at least moderate intensity) and to also complete resistance training (resistance bands or free weights) at least twice weekly over a 12-week period supervised by an exercise professional. The resistance training will be personalized, aiming for 6 to 10 exercises targeting the major muscle groups, progressing to 3 sets of 8 to 12 repetitions. Exercise prescriptions will be developed and monitored by an exercise professional with weekly follow-up meetings and supported with a web application (Physiotec) that allows customizable exercise prescriptions, tracking of exercise completion, and video tutorials. Participants will receive one counselling session on healthy eating and physical activity at the start of the study along with an exercise manual.

Participants will receive one counselling session on healthy eating and physical activity at the start of the study.

Outcomes

Primary Outcome Measures

Recruitment
We will measure recruitment-success percentage and will record reasons for non-participation.
Adherence to Exercise Training
Adherence to the home-based exercise program (aerobic and resistance) will be measured through an exercise diary completed by participants and reviewed through weekly communication.
Study Retention
Retention will be assessed by measuring attrition throughout the intervention period.
Adverse Events During Exercise Training (Safety and Tolerability)
Adverse events with exercise training will be assessed throughout the study period.
Participant Satisfaction with Exercise Training and Study Participation (Exercise Group)
Multiple choice and free form questionnaire assessing the participants' satisfaction with the home exercise program and study intervention.
Participant Satisfaction with Study Participation (Control Group)
Multiple choice and free form questionnaire assessing participants' satisfaction with the study intervention.

Secondary Outcome Measures

Total Cholesterol
Participants will undergo fasting blood work to assess total cholesterol levels.
Triglycerides
Participants will undergo fasting blood work to assess triglyceride levels.
High Density Lipoprotein
Participants will undergo fasting blood work to assess high density lipoprotein.
Low Density Lipoprotein
Participants will undergo fasting blood work to assess low density lipoprotein.
Fasting Blood Glucose Levels
Fasting blood glucose levels will be ascertained from blood testing results.
Hemoglobin A1C
Hemoglobin A1C results will be assessed from bloodwork, which allows assessment of the average level of blood sugar over the previous 3 months.
Insulin Resistance
Insulin resistance will be captured using the Homeostatic Model Assessment of Insulin Resistance protocol (fasting insulin * fasting blood glucose).
C-peptide Levels
C-peptide levels will be analyzed via blood testing in a subset of participants on exogenous insulin therapy.
C-reactive Protein Levels
C-reactive protein levels will be ascertained from blood testing results.
Health Related Quality of Life assessed with the Short-Form 36 Health Survey
The Short-Form 36 Health Survey (SF-36) will be used to assess general health-related quality of life. The SF-36 consists of eight scaled scores (total score ranging from 0 to 100), with lower scores representing lower health-related quality of life.
Physical Function assessed with the Short-Physical Performance Battery
The Short-Physical Performance Battery will assess participants' balance, gait speed, and ability to rise from a chair 5 times.
Physical Activity Questionnaire
The Physical Activity Scale for the Elderly (PASE) is a short survey created to assess physical activity levels in older adults. The PASE uses frequency, duration, and intensity level of physical activities over one week to assign a score (ranging from 0 to 793), with higher scores indicating greater levels of physical activity.
Self-Efficacy with Exercise Training (Exercise Group)
The Exercise Self-Efficacy Scale (ESES) is a 4-point rating Likert scale in which participants rate their confidence with carrying out their regular physical activities and exercise. The ESES uses a 100-point percentage scale, ranging from 0% (not at all confident) to 100% (highly confident). Higher scores represent higher self-efficacy to exercise.
Self-Efficacy with Exercise Training (Control Group)
The Exercise Self-Efficacy Scale (ESES) is a 4-point rating Likert scale in which participants rate their confidence with carrying out their regular physical activities and exercise. The ESES uses a 100-point percentage scale, ranging from 0% (not at all confident) to 100% (highly confident). Higher scores represent higher self-efficacy to exercise.
Nutritional Questionnaire
The Rapid Eating and Activity Assessment for Patients (REAP) survey assesses nutrient intake and helps with lifestyle counseling. The survey contains 27 questions with higher scores indicating higher diet quality (score range, 27 to 81).
Lifestyle and Environmental Questionnaire
The Lifestyle and Environmental Questionnaire is a questionnaire developed by our research team to assess familiarity and comfort levels surrounding technology, barriers to exercise and assess previous experience with exercise. It is composed of 10 multiple-choice questions with each question assessed independently.

Full Information

First Posted
June 17, 2021
Last Updated
November 25, 2022
Sponsor
University Health Network, Toronto
Collaborators
Canadian National Transplant Research Program, University of Toronto
search

1. Study Identification

Unique Protocol Identification Number
NCT04965142
Brief Title
Feasibility of a Home Exercise Program to Manage Post-transplant Metabolic Syndrome
Official Title
Feasibility of a Home-Based Exercise Program in Lung and Liver Transplant Recipients for Management of Post-Transplant Metabolic Syndrome: A Pilot Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 19, 2021 (Actual)
Primary Completion Date
July 30, 2023 (Anticipated)
Study Completion Date
July 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto
Collaborators
Canadian National Transplant Research Program, University of Toronto

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Post-transplant metabolic syndrome (PTMS) affects about 50% liver transplant (OLT) and 25% lung transplant (LTx) recipients at 12-18 months post-transplant. PTMS (comprised of glucose intolerance, obesity, hypercholesterolemia and hypertension) has been associated with increased risk for cardiovascular morbidity and long-term survival. Exercise studies in the early post-transplant period have shown some benefits on PTMS risk factors with facility-based training, but it remains unclear if exercise can be sustained in the home environment with sufficient adherence or training intensity to impact PTMS beyond the early post-transplant period. Objectives: 1) To evaluate the feasibility of a three-month individualized, virtual home-based exercise training program in OLT and LTx recipients starting at 1 year post-transplant. 2) To assess estimates of intervention efficacy on elements of PTMS, insulin resistance, exercise self-efficacy, and health related quality of life (HRQL). Methods: 20 OLT and 20 LTx recipients with 2 or more PTMS risk factors at 12-18 months post-transplant will be randomized to a home-based exercise program versus usual care. The exercise group will undergo aerobic training 3 to 5 times per week with resistance training at least twice weekly over a 12-week period. Exercises will be demonstrated by a qualified exercise professional during the first visit with weekly phone and video calls to guide exercise progression, ease communication and promote exercise self-efficacy and adherence based on guiding behavioral principles. As secondary measures, PTMS, insulin resistance, body composition (optional), HRQL, and assessment of self-efficacy will be assessed at baseline and 12-weeks.
Detailed Description
Both LTx and OLT recipients have several common risk factors for PTMS including significant weight gain, immunosuppression, and physical inactivity. These risk factors have been shown to be partly reversible with an active lifestyle. A home-based exercise program may prove to be an effective post-transplant intervention for improving the metabolic profile of transplant recipients. Primary objective: To evaluate the feasibility (recruitment rate, program adherence, attrition, safety, and participant satisfaction) of a 12 week individualized, virtual home-based aerobic and resistance training program in OLT and LTx recipients that are 12-18 months post-transplant. Secondary objective: To assess estimates of intervention efficacy on elements of PTMS, insulin resistance, exercise self-efficacy, and HRQL. Hypotheses: We hypothesize that it will be feasible to recruit both OLT and LTx recipients into a home-based exercise program with ≥ 70% adherence to the prescribed exercise dose. Secondary Objective: PTMS risk factors, self-efficacy and HRQL will be improved with a home-based exercise program. The home-based exercise group will be asked to exercise 3 to 5 times per week (≥ 150 minutes of aerobic exercises at moderate intensity) and to also complete resistance training (resistance bands or free weights) over a 12-week period with the guidance of a qualified exercise professional. The control group will be counselled by a qualified exercise professional on the importance of accumulating at least 150 minutes of moderate physical activity during the first assessment at the beginning of the study. Both groups will also receive physical activity trackers (Fitbit), exercise training or physical activity logs, and a counselling session by the dietitian at the start of the study. A home-based exercise program may prove to be an effective post-transplant intervention for improving the metabolic profile of transplant recipients. Characterizing the feasibility, adherence, and effect estimates of home-based exercise training constitutes the first key step in promoting a healthy lifestyle in transplant recipients, and supporting the development of future trials aimed at reducing the morbidity associated with PTMS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome
Keywords
Lung Transplant Recipients, Liver Transplant Recipients, Exercise Training

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Lung and liver transplant recipients will be randomized to home exercise group versus usual care group.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Home Exercise Group
Arm Type
Experimental
Arm Description
The home-based exercise group will be asked to exercise 3 to 5 times per week (≥ 150 minutes of aerobic exercises (i.e. walking, cycling, or treadmill) of at least moderate intensity) and to also complete resistance training (resistance bands or free weights) at least twice weekly over a 12-week period supervised by an exercise professional. The resistance training will be personalized, aiming for 6 to 10 exercises targeting the major muscle groups, progressing to 3 sets of 8 to 12 repetitions. Exercise prescriptions will be developed and monitored by an exercise professional with weekly follow-up meetings and supported with a web application (Physiotec) that allows customizable exercise prescriptions, tracking of exercise completion, and video tutorials. Participants will receive one counselling session on healthy eating and physical activity at the start of the study along with an exercise manual.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Participants will receive one counselling session on healthy eating and physical activity at the start of the study.
Intervention Type
Behavioral
Intervention Name(s)
Exercise Training
Intervention Description
The intervention group will be asked to complete aerobic exercises 3 to 5 times per week (≥ 150 minutes of at least moderate aerobic intensity) and resistance training at least twice a week over a 12-week period.
Primary Outcome Measure Information:
Title
Recruitment
Description
We will measure recruitment-success percentage and will record reasons for non-participation.
Time Frame
When recruitment is complete (approximately 18 months after study initiation)
Title
Adherence to Exercise Training
Description
Adherence to the home-based exercise program (aerobic and resistance) will be measured through an exercise diary completed by participants and reviewed through weekly communication.
Time Frame
Over a 12 week period
Title
Study Retention
Description
Retention will be assessed by measuring attrition throughout the intervention period.
Time Frame
Over a 12 week period
Title
Adverse Events During Exercise Training (Safety and Tolerability)
Description
Adverse events with exercise training will be assessed throughout the study period.
Time Frame
Over a 12 week period
Title
Participant Satisfaction with Exercise Training and Study Participation (Exercise Group)
Description
Multiple choice and free form questionnaire assessing the participants' satisfaction with the home exercise program and study intervention.
Time Frame
Change over the study period assessed at weeks 2, 6, and 12
Title
Participant Satisfaction with Study Participation (Control Group)
Description
Multiple choice and free form questionnaire assessing participants' satisfaction with the study intervention.
Time Frame
12 weeks from baseline assessment
Secondary Outcome Measure Information:
Title
Total Cholesterol
Description
Participants will undergo fasting blood work to assess total cholesterol levels.
Time Frame
Change from baseline at 12 weeks
Title
Triglycerides
Description
Participants will undergo fasting blood work to assess triglyceride levels.
Time Frame
Change from baseline at 12 weeks
Title
High Density Lipoprotein
Description
Participants will undergo fasting blood work to assess high density lipoprotein.
Time Frame
Change from baseline at 12 weeks
Title
Low Density Lipoprotein
Description
Participants will undergo fasting blood work to assess low density lipoprotein.
Time Frame
Change from baseline at 12 weeks
Title
Fasting Blood Glucose Levels
Description
Fasting blood glucose levels will be ascertained from blood testing results.
Time Frame
Change from baseline at 12 weeks
Title
Hemoglobin A1C
Description
Hemoglobin A1C results will be assessed from bloodwork, which allows assessment of the average level of blood sugar over the previous 3 months.
Time Frame
Change from baseline at 12 weeks
Title
Insulin Resistance
Description
Insulin resistance will be captured using the Homeostatic Model Assessment of Insulin Resistance protocol (fasting insulin * fasting blood glucose).
Time Frame
Change from baseline at 12 weeks
Title
C-peptide Levels
Description
C-peptide levels will be analyzed via blood testing in a subset of participants on exogenous insulin therapy.
Time Frame
Change from baseline at 12 weeks
Title
C-reactive Protein Levels
Description
C-reactive protein levels will be ascertained from blood testing results.
Time Frame
Change from baseline at 12 weeks
Title
Health Related Quality of Life assessed with the Short-Form 36 Health Survey
Description
The Short-Form 36 Health Survey (SF-36) will be used to assess general health-related quality of life. The SF-36 consists of eight scaled scores (total score ranging from 0 to 100), with lower scores representing lower health-related quality of life.
Time Frame
Change from baseline at 12 weeks
Title
Physical Function assessed with the Short-Physical Performance Battery
Description
The Short-Physical Performance Battery will assess participants' balance, gait speed, and ability to rise from a chair 5 times.
Time Frame
Change from baseline at 12 weeks
Title
Physical Activity Questionnaire
Description
The Physical Activity Scale for the Elderly (PASE) is a short survey created to assess physical activity levels in older adults. The PASE uses frequency, duration, and intensity level of physical activities over one week to assign a score (ranging from 0 to 793), with higher scores indicating greater levels of physical activity.
Time Frame
Change from baseline at 12 weeks
Title
Self-Efficacy with Exercise Training (Exercise Group)
Description
The Exercise Self-Efficacy Scale (ESES) is a 4-point rating Likert scale in which participants rate their confidence with carrying out their regular physical activities and exercise. The ESES uses a 100-point percentage scale, ranging from 0% (not at all confident) to 100% (highly confident). Higher scores represent higher self-efficacy to exercise.
Time Frame
Change from baseline at 2, 6, and 12 weeks
Title
Self-Efficacy with Exercise Training (Control Group)
Description
The Exercise Self-Efficacy Scale (ESES) is a 4-point rating Likert scale in which participants rate their confidence with carrying out their regular physical activities and exercise. The ESES uses a 100-point percentage scale, ranging from 0% (not at all confident) to 100% (highly confident). Higher scores represent higher self-efficacy to exercise.
Time Frame
Change from baseline at 12 weeks
Title
Nutritional Questionnaire
Description
The Rapid Eating and Activity Assessment for Patients (REAP) survey assesses nutrient intake and helps with lifestyle counseling. The survey contains 27 questions with higher scores indicating higher diet quality (score range, 27 to 81).
Time Frame
Change from baseline at 12 weeks
Title
Lifestyle and Environmental Questionnaire
Description
The Lifestyle and Environmental Questionnaire is a questionnaire developed by our research team to assess familiarity and comfort levels surrounding technology, barriers to exercise and assess previous experience with exercise. It is composed of 10 multiple-choice questions with each question assessed independently.
Time Frame
Baseline
Other Pre-specified Outcome Measures:
Title
Liver Fibrosis
Description
A liver Fibroscan (transient elastography) assessment will be performed in a subset of liver transplant recipients to assess the degree of liver fibrosis (thickening/scarring of tissues). The fibrosis result is measured in kilopascals (kPa). This test is optional for study participants.
Time Frame
Change from baseline at 12 weeks
Title
Fat Free Mass Index
Description
Fat-free mass index will be evaluated using bioelectrical impedance. This test is optional for study participants.
Time Frame
Change from baseline at 12 weeks
Title
Body Fat Mass Index
Description
Body Fat Mass Index will be evaluated using bioelectrical impedance. This test is optional for study participants.
Time Frame
Change from baseline at 12 weeks
Title
Electrocardiogram
Description
12 Lead Electrocardiogram will be performed in all study participants. The following electrocardiogram parameters (p wave, QRS complex, QT interval, T waves, and ST segments) will be assessed to ensure they are within normal limits before starting exercise program.
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult lung and liver transplant recipients 12 to 18 months post-transplant Presence of 2 or more metabolic risk factors (hypertension, hyperlipidemia, diabetes, obesity) Exclusion Criteria: Active cardiovascular disease (recent heart attack, significant coronary artery disease on cardiac catheterization, heart failure, uncontrolled arrhythmias, chest pain, dizziness, or fainting in the last 3 months) Neuro-muscular disease or orthopedic limitations Physically active with ≥ 150 minutes/week of moderate-intensity aerobic physical activity Residing outside the province of Ontario
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dmitry Rozenberg, MD PhD
Phone
416-340-4800
Ext
7358
Email
Dmitry.Rozenberg@uhn.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dmitry Rozenberg, MD PhD
Organizational Affiliation
University Health Network /University of Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Health Network - Toronto General Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 2C4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dmitry Rozenberg
Phone
4163404800
Ext
7358
Email
Dmitry.Rozenberg@uhn.ca

12. IPD Sharing Statement

Citations:
PubMed Identifier
35319467
Citation
Rozenberg D, Santa Mina D, Nourouzpour S, Camacho Perez E, Stewart BL, Wickerson L, Tsien C, Selzner N, Shore J, Aversa M, Woo M, Holdsworth S, Prevost K, Park J, Azhie A, Huszti E, McLeod E, Dales S, Bhat M. Feasibility of a Home-Based Exercise Program for Managing Posttransplant Metabolic Syndrome in Lung and Liver Transplant Recipients: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2022 Mar 23;11(3):e35700. doi: 10.2196/35700.
Results Reference
derived

Learn more about this trial

Feasibility of a Home Exercise Program to Manage Post-transplant Metabolic Syndrome

We'll reach out to this number within 24 hrs